Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...
Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...
Ocular Therapeutix and Eyepoint Pharmaceuticals are developing competing eye treatments, and the competition appears to be ...
EXTON, PA — Frontage Laboratories, Inc. announced a major expansion of its early phase clinical research capabilities across ...
7hOpinion
Why raising NHS spending on new drugs by 25% is the wrong decision – health economist’s view
This change has come from wider government concerns over protecting UK-based pharmaceutical manufacturing, and now from ...
UC Santa Cruz team achieves synthesis of beneficial neurochemical in just two steps, promising to break a bottleneck in drug ...
As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...
Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to ...
During pre-submission meetings, the agency told Corcept on “several occasions” to “expect significant review issues” if it ...
Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...
This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...
The biotech is now banking on secondary data signals as it progresses ignaseclant to late-stage trials in Charcot-Marie-Tooth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results